发明名称 |
Oral Composition |
摘要 |
The present invention relates to an oral composition having an enhanced solubility of an alkyl galactoside while holding an inhibiting effect on coaggregation of the alkyl galactoside well.;The present invention provides an oral composition comprising the following components: (A) 0.001 mass % or more and 1 mass % or less of a compound represented by the following formula (I):;;wherein R is an optionally substituted linear or branched alkyl group having 8 to 18 carbon atoms, G is a galactose residue, E is a hydrogen atom or a methyl group, m is an integer of 0 to 200, and n is an integer of 1 to 30; (B) 0.001 mass % or more and 0.1 mass % or less of a cationic bactericide; and (C) 35 mass % or more of water. |
申请公布号 |
US2016324748(A1) |
申请公布日期 |
2016.11.10 |
申请号 |
US201315108445 |
申请日期 |
2013.12.27 |
申请人 |
KAO CORPORATION |
发明人 |
OGIHARA Aya;ITANO Morihide |
分类号 |
A61K8/60;C07H15/04;A61K8/43;A61K8/49;A61K8/92;A61Q11/00;A61K8/41 |
主分类号 |
A61K8/60 |
代理机构 |
|
代理人 |
|
主权项 |
1. An oral composition comprising the following components (A), (B), and (C):
(A) 0.001 mass % or more and 1 mass % or less of a compound represented by the following formula (I):wherein R represents an optionally substituted linear or branched alkyl group having 8 to 18 carbon atoms, G represents a galactose residue, E represents a hydrogen atom or a methyl group, m represents an integer of 0 to 200, and n represents an integer of 1 to 30;
(B) 0.001 mass % or more and 0.1 mass % or less of a cationic bactericide; and (C) 35 mass % or more of water. |
地址 |
Tokyo JP |